Cleavage of GSK-3β by calpain counteracts the inhibitory effect of Ser9 phosphorylation on GSK-3β activity induced by H2O 2

Journal of Neurochemistry

Volumn 126, Issue 2, 2013, Pages 234-242

  Feng, Ye ^a   Xia, Yiyuan ^a   Yu, Guang ^a   Shu, Xiji ^b   Ge, Haoliang ^a   Zeng, Kuan ^a   Wang, Jianzhi ^a   Wang, Xiaochuan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIANGHAN UNIVERSITY   (China)

Author keywords

calpain; GSK 3 ; HEK293 Tau cells; hydrogen peroxide (H2O 2)

Indexed keywords

CALCIUM ION; CALPAIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; PROTEIN P53; SERINE; TAU PROTEIN; THREONINE;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

CALPAIN; GSK-3Β; HEK293/TAU CELLS; HYDROGEN PEROXIDE (H2O2);

CALCIUM; CALPAIN; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEINS; HEK293 CELLS; HUMANS; HYDROGEN PEROXIDE; INTRACELLULAR FLUID; MALONDIALDEHYDE; MUTATION; ONCOGENE PROTEIN V-AKT; OXIDATIVE STRESS; PHOSPHORYLATION; SERINE; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE; TAU PROTEINS; TRANSFECTION; UP-REGULATION;

EID: 84879945041     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12285     Document Type: Article

References (42)

1. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., and, Hemmings B. A., (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551.
2. Blair A. S., Hajduch E., Litherland G. J., and, Hundal H. S., (1999) Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways. J. Biol. Chem. 274, 36293-36299.
3. Cedazo-Minguez A., Popescu B. O., Blanco-Millan J. M., Akterin S., Pei J. J., Winblad B., and, Cowbum R. R., (2003) Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β. J. Neurochem. 87, 1152-1164.
4. Cicchillitti L., Fasanaro P., Biglioli P., Capogrossi M. C., and, Martelli F., (2003) Oxidative stress induces protein phosphatase 2A-dependent dephosphorylation of the pocket proteins pRb, p107, and p130. J. Biol. Chem. 278, 19509-19517.
5. Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C., and, Pearl L. H., (2001) Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
6. Davis D. R., Anderton B. H., Brion J. P., Reynolds C. H., and, Hanger D. P., (1997) Oxidative stress induces dephosphorylation of Tau in rat brain primary neuronal cultures. J. Neurochem. 68, 1590-1597.
7. Doble B. W., and, Woodgett J. R., (2003) GSK-3 tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186.
8. Dugo L., Collin M., and, Thiemermann C., (2007) Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock 27, 113-123.
9. Embi N., Rylatt D. B., and, Cohen P., (1980) Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107, 519-527.
10. Feng Y., and, Wang X., (2012) Antioxidant therapies for Alzheimer's disease. Oxid. Med. Cell. Longev. 2012, 472932.
11. Frame S., and, Cohen P., (2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16.
12. Goll D. E., Thompson V. F., Li H., Wei W., and, Cong J., (2003) The calpain system. Physiol. Rev. 83, 731-801.
13. Goñi-Oliver P., Lucas J. J., Avila J., and, Hernández F., (2007) N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation. J. Biol. Chem. 282, 22406-22413.
14. Goñi-Oliver P., Avila J., and, Hernández F., (2011) Calpain regulates N-terminal interaction of GSK-3β with 14-3-3ξ, p53 and PKB but not with axin. Neurochem. Int. 59, 97-100.
15. Goode N., Hughes K., Woodgett J. R., and, Parker P. J., (1992) Differential regulation of glycogen synthase kinase-3 β by protein kinase C isotypes. J. Biol. Chem. 267, 16878-16882.
16. Grimes C. A., and, Jope R. S., (2001) The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Prog. Neurobiol. 65, 391-426.
17. ter Haar E., Coll J. T., Austen D. A., Hsiao H. M., Swenson L., and, Jain J., (2001) Structure of GSK3beta reveals a primed phosphorylation mechanism. Nat. Struct. Biol. 8, 593-596.
18. Hartigan J. A., and, Johnson G. V., (1999) Transient increases in intraceltutar calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J. Biol. Chem. 274, 21395-21401.
19. Harwood A. J., (2001) Regulation of GSK-3: A cellular multiprocessor. Cell 105, 821-824.
20. Henriksen E. J., and, Dokken B. B., (2006) Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr. Drug Targets 7, 1435-1441.
21. Hoeflich K. P., Luo J., Rubie E. A., Tsao M. S., Jin O., and, Woodgett J. R., (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-kappaB activation. Nature 406, 86-90.
22. 2+ oscillations in human aortic endothelial cells stimulated by histamine. J. Biol. Chem. 277, 32546-32551.
23. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., and, Imahori K., (1992) Tau protein kinase I converts normal Tau protein into A68-like component of paired helical filamen. J. Biol. Chem. 267, 10897-10901.
24. Jope R. S., (2004) Inhibition of glycogen synthase kinase-3: a potential therapeutic target of lithium. Clin. Neurosci. Res. 4, 171-179.
25. Jope R. S., and, Johnson G. V., (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102.
26. Jope R. S., and, Roh M. S., (2006) Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr. Drug Targets 7, 1421-1434.
27. Jope R. S., Yuskaitis C. J., and, Beurel E., (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 32, 577-595.
28. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T., and, Hisanaga S., (2000) Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 275, 17166-17172.
29. Liang M. H., and, Chuang D. M., (2007) Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J. Biol. Chem. 282, 3904-3917.
30. Nair V. D., and, Olanow C. W., (2008) Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses. J. Biol. Chem. 283, 15469-15478.
31. Pei J. J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., and, Cowburn R. F., (1999) Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 58, 1010-1019.
32. Peng T. I., and, Jou M. J., (2010) Oxidative stress caused by mitochondrial calcium overload. Ann. N. Y. Acad. Sci. 1201, 183-188.
33. Phiel C. J., Wilson C. A., Lee V. M., and, Klein P. S., (2003) GSK-3alpha regulates production of Alzheimer's disease amyloid-β peptide. Nature 423, 435-439.
34. Planel E., Sun X. Y., and, Takashima A., (2002) Role of GSK-3β in Alzheimer's disease pathology. Drug Dev. Res. 56, 491-510.
35. Su Y., Ryder J., Li B., et al,. (2004) Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing. Biochemistry 43, 6899-6908.
36. Takahashi-Yanaga F., Shiraishi F., Hirata M., Miwa Y., Morimoto S., and, Sasaguri T., (2004) Glycogen synthase kinase-3β is tyrosine-phosphorylated by MEK1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 316, 411-415.
37. Wang Q. M., Park I. K., Fiol C. J., Roach P. J., and, DePaoli-Roach A. A., (1994a) Isoform differences in substrate recognition by glycogen synthase kinases 3 alpha and 3 β in the phosphorylation of phosphatase inhibitor 2. Biochemistry 33, 143-147.
38. Wang Q. M., Fiol C. J., DePaoli-Roach A. A., and, Roach P. J., (1994b) Glycogen synthase kinase-3β is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14566-14574.
39. Woodgett J. R., (1990) Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
40. Woodgett J. R., (1991) cDNA cloning and properties of glycogen synthase kinase-3. Methods Enzymol. 200, 564-577.
41. Yu G., Li Y., Tian Q., Liu R., Wang Q., Wang J. Z., and, Wang X. C., (2011) Berberine attenuates calyculin A-induced cytotoxicity and Tau hyperphosphorylation in HEK293 cells. J. Alzheimers Dis. 24, 525-535.
42. 2+ oscillation frequency regulates agonist-stimulated gene expression in vascular endothelial cells. J. Cell Sci. 121 (Pt 15), 2511-2518.